These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the quarterly period ended June 30, 2016
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the Transition Period from to
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
76-0346924
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification Number)
|
Large accelerated filer
|
|
x
|
|
Accelerated filer
|
|
¨
|
Non-accelerated filer
|
|
¨
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
¨
|
|
|
Item
|
Page
|
|
|
|
|
|
|
|
|
June 30,
2016 |
|
December 31,
2015 |
||||
|
|
|
|
|
||||
|
|
(in thousands of dollars, except
par values and share amounts)
|
||||||
ASSETS
|
|
|
|
|
||||
Current assets
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
770,997
|
|
|
$
|
662,525
|
|
Marketable securities
|
|
352,021
|
|
|
520,144
|
|
||
Accounts receivable, net
|
|
582,855
|
|
|
508,532
|
|
||
Inventories
|
|
448,526
|
|
|
434,060
|
|
||
Prepaid expenses and other current assets
|
|
35,642
|
|
|
14,489
|
|
||
Deferred income taxes
|
|
—
|
|
|
35,439
|
|
||
Total current assets
|
|
2,190,041
|
|
|
2,175,189
|
|
||
Property, plant and equipment, net
|
|
3,230,523
|
|
|
3,004,067
|
|
||
Equity investments
|
|
8,929
|
|
|
9,208
|
|
||
Other assets, net
|
|
|
|
|
||||
Intangible assets, net
|
|
208,376
|
|
|
213,404
|
|
||
Deferred charges and other assets, net
|
|
282,695
|
|
|
167,417
|
|
||
Total other assets, net
|
|
491,071
|
|
|
380,821
|
|
||
Total assets
|
|
$
|
5,920,564
|
|
|
$
|
5,569,285
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
||||
Current liabilities
|
|
|
|
|
||||
Accounts and notes payable
|
|
$
|
307,116
|
|
|
$
|
235,329
|
|
Accrued liabilities
|
|
312,985
|
|
|
287,313
|
|
||
Total current liabilities
|
|
620,101
|
|
|
522,642
|
|
||
Long-term debt, net
|
|
758,453
|
|
|
758,148
|
|
||
Deferred income taxes
|
|
664,987
|
|
|
575,603
|
|
||
Other liabilities
|
|
139,587
|
|
|
150,961
|
|
||
Total liabilities
|
|
2,183,128
|
|
|
2,007,354
|
|
||
Commitments and contingencies (Notes 8 and 18)
|
|
|
|
|
|
|
||
Stockholders' equity
|
|
|
|
|
||||
Preferred stock, $0.01 par value, 50,000,000 shares authorized;
no shares issued and outstanding
|
|
—
|
|
|
—
|
|
||
Common stock, $0.01 par value, 300,000,000 shares authorized;
134,651,380 and 134,663,244 shares issued at June 30, 2016 and
December 31, 2015, respectively
|
|
1,347
|
|
|
1,347
|
|
||
Common stock, held in treasury, at cost; 5,867,617 and 4,444,898 shares
at June 30, 2016 and December 31, 2015, respectively
|
|
(322,802
|
)
|
|
(258,312
|
)
|
||
Additional paid-in capital
|
|
545,797
|
|
|
542,148
|
|
||
Retained earnings
|
|
3,296,922
|
|
|
3,109,987
|
|
||
Accumulated other comprehensive loss
|
|
(82,101
|
)
|
|
(129,292
|
)
|
||
Total Westlake Chemical Corporation stockholders' equity
|
|
3,439,163
|
|
|
3,265,878
|
|
||
Noncontrolling interests
|
|
298,273
|
|
|
296,053
|
|
||
Total equity
|
|
3,737,436
|
|
|
3,561,931
|
|
||
Total liabilities and equity
|
|
$
|
5,920,564
|
|
|
$
|
5,569,285
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
(in thousands of dollars, except per share data and share amounts)
|
||||||||||||||
Net sales
|
|
$
|
1,086,061
|
|
|
$
|
1,185,002
|
|
|
$
|
2,061,248
|
|
|
$
|
2,288,533
|
|
Cost of sales
|
|
844,695
|
|
|
831,821
|
|
|
1,564,297
|
|
|
1,650,806
|
|
||||
Gross profit
|
|
241,366
|
|
|
353,181
|
|
|
496,951
|
|
|
637,727
|
|
||||
Selling, general and administrative expenses
|
|
61,428
|
|
|
57,807
|
|
|
114,737
|
|
|
113,073
|
|
||||
Income from operations
|
|
179,938
|
|
|
295,374
|
|
|
382,214
|
|
|
524,654
|
|
||||
Other income (expense)
|
|
|
|
|
|
|
|
|
||||||||
Interest expense
|
|
(5,915
|
)
|
|
(8,958
|
)
|
|
(12,600
|
)
|
|
(18,549
|
)
|
||||
Other income, net
|
|
8,181
|
|
|
22,058
|
|
|
10,826
|
|
|
31,154
|
|
||||
Income before income taxes
|
|
182,204
|
|
|
308,474
|
|
|
380,440
|
|
|
537,259
|
|
||||
Provision for income taxes
|
|
66,584
|
|
|
98,413
|
|
|
135,884
|
|
|
176,791
|
|
||||
Net income
|
|
115,620
|
|
|
210,061
|
|
|
244,556
|
|
|
360,468
|
|
||||
Net income attributable to noncontrolling interests
|
|
4,496
|
|
|
4,966
|
|
|
10,304
|
|
|
9,031
|
|
||||
Net income attributable to
Westlake Chemical Corporation
|
|
$
|
111,124
|
|
|
$
|
205,095
|
|
|
$
|
234,252
|
|
|
$
|
351,437
|
|
Earnings per common share attributable to
Westlake Chemical Corporation:
|
|
|
|
|
|
|
|
|
||||||||
Basic
|
|
$
|
0.85
|
|
|
$
|
1.55
|
|
|
$
|
1.80
|
|
|
$
|
2.65
|
|
Diluted
|
|
$
|
0.85
|
|
|
$
|
1.54
|
|
|
$
|
1.79
|
|
|
$
|
2.64
|
|
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
||||||||
Basic
|
|
129,583,224
|
|
|
132,538,123
|
|
|
129,886,594
|
|
|
132,625,857
|
|
||||
Diluted
|
|
129,980,527
|
|
|
133,044,975
|
|
|
130,290,521
|
|
|
133,124,697
|
|
||||
Dividends per common share
|
|
$
|
0.1815
|
|
|
$
|
0.1650
|
|
|
$
|
0.3630
|
|
|
$
|
0.3300
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
(in thousands of dollars)
|
||||||||||||||
Net income
|
|
$
|
115,620
|
|
|
$
|
210,061
|
|
|
$
|
244,556
|
|
|
$
|
360,468
|
|
Other comprehensive (loss) income, net of income taxes
|
|
|
|
|
|
|
|
|
||||||||
Pension and other post-retirement benefits liability
|
|
|
|
|
|
|
|
|
||||||||
Pension and other post-retirement reserves
adjustment (excluding amortization)
|
|
(206
|
)
|
|
(186
|
)
|
|
(206
|
)
|
|
(186
|
)
|
||||
Amortization of benefits liability
|
|
369
|
|
|
675
|
|
|
703
|
|
|
1,327
|
|
||||
Income tax provision on pension and other
post-retirement benefits liability
|
|
(63
|
)
|
|
(164
|
)
|
|
(191
|
)
|
|
(389
|
)
|
||||
Foreign currency translation adjustments
|
|
(13,500
|
)
|
|
17,872
|
|
|
9,305
|
|
|
(41,826
|
)
|
||||
Available-for-sale investments
|
|
|
|
|
|
|
|
|
||||||||
Unrealized holding gains on investments
|
|
35,545
|
|
|
3,077
|
|
|
59,973
|
|
|
4,703
|
|
||||
Reclassification of net realized gains
to net income
|
|
(1,267
|
)
|
|
(3,795
|
)
|
|
(1,319
|
)
|
|
(3,795
|
)
|
||||
Income tax (provision) benefit on
available-for-sale investments
|
|
(12,316
|
)
|
|
259
|
|
|
(21,074
|
)
|
|
(325
|
)
|
||||
Other comprehensive income (loss)
|
|
8,562
|
|
|
17,738
|
|
|
47,191
|
|
|
(40,491
|
)
|
||||
Comprehensive income
|
|
124,182
|
|
|
227,799
|
|
|
291,747
|
|
|
319,977
|
|
||||
Comprehensive income attributable to
noncontrolling interests, net of tax
|
|
4,496
|
|
|
4,966
|
|
|
10,304
|
|
|
9,031
|
|
||||
Comprehensive income attributable to
Westlake Chemical Corporation
|
|
$
|
119,686
|
|
|
$
|
222,833
|
|
|
$
|
281,443
|
|
|
$
|
310,946
|
|
|
|
Six Months Ended June 30,
|
||||||
|
|
2016
|
|
2015
|
||||
|
|
|
|
|
||||
|
|
(in thousands of dollars)
|
||||||
Cash flows from operating activities
|
|
|
|
|
||||
Net income
|
|
$
|
244,556
|
|
|
$
|
360,468
|
|
Adjustments to reconcile net income to net cash provided by operating activities
|
|
|
|
|
||||
Depreciation and amortization
|
|
132,964
|
|
|
118,981
|
|
||
Provision for doubtful accounts
|
|
403
|
|
|
228
|
|
||
Amortization of debt issuance costs
|
|
417
|
|
|
1,002
|
|
||
Stock-based compensation expense
|
|
5,084
|
|
|
4,905
|
|
||
Loss from disposition of property, plant and equipment
|
|
3,331
|
|
|
890
|
|
||
Gains from sales of securities
|
|
(1,319
|
)
|
|
(3,795
|
)
|
||
Gain on acquisition, net of loss on the fair value remeasurement
of preexisting equity interest
|
|
—
|
|
|
(21,045
|
)
|
||
Impairment of equity method investment
|
|
—
|
|
|
4,925
|
|
||
Deferred income taxes
|
|
102,990
|
|
|
3,088
|
|
||
Windfall tax benefits from share-based payment arrangements
|
|
(319
|
)
|
|
(1,895
|
)
|
||
Loss (income) from equity method investments, net of dividends
|
|
279
|
|
|
(1,760
|
)
|
||
Other losses, net
|
|
1,210
|
|
|
423
|
|
||
Changes in operating assets and liabilities
|
|
|
|
|
||||
Accounts receivable
|
|
(72,996
|
)
|
|
(22,380
|
)
|
||
Inventories
|
|
(12,719
|
)
|
|
50,115
|
|
||
Prepaid expenses and other current assets
|
|
(12,586
|
)
|
|
(10,844
|
)
|
||
Accounts payable
|
|
54,394
|
|
|
(2,327
|
)
|
||
Accrued liabilities
|
|
(1,617
|
)
|
|
(40,526
|
)
|
||
Other, net
|
|
(74,180
|
)
|
|
(5,098
|
)
|
||
Net cash provided by operating activities
|
|
369,892
|
|
|
435,355
|
|
||
Cash flows from investing activities
|
|
|
|
|
||||
Acquisition of business, net of cash acquired
|
|
—
|
|
|
15,782
|
|
||
Additions to property, plant and equipment
|
|
(287,160
|
)
|
|
(203,933
|
)
|
||
Proceeds from disposition of assets
|
|
105
|
|
|
—
|
|
||
Proceeds from sales and maturities of securities
|
|
302,432
|
|
|
15,037
|
|
||
Purchase of securities
|
|
(138,422
|
)
|
|
—
|
|
||
Settlements of derivative instruments
|
|
(3,372
|
)
|
|
(1,174
|
)
|
||
Net cash used for investing activities
|
|
(126,417
|
)
|
|
(174,288
|
)
|
||
Cash flows from financing activities
|
|
|
|
|
||||
Debt issuance costs
|
|
(9,700
|
)
|
|
—
|
|
||
Dividends paid
|
|
(47,317
|
)
|
|
(43,896
|
)
|
||
Distributions to noncontrolling interests
|
|
(8,084
|
)
|
|
(7,218
|
)
|
||
Proceeds from exercise of stock options
|
|
481
|
|
|
831
|
|
||
Proceeds from issuance of notes payable
|
|
3,842
|
|
|
2,392
|
|
||
Repayment of notes payable
|
|
(8,626
|
)
|
|
(4,299
|
)
|
||
Repurchase of common stock for treasury
|
|
(67,404
|
)
|
|
(62,804
|
)
|
||
Windfall tax benefits from share-based payment arrangements
|
|
319
|
|
|
1,895
|
|
||
Net cash used for financing activities
|
|
(136,489
|
)
|
|
(113,099
|
)
|
||
Effect of exchange rate changes on cash and cash equivalents
|
|
1,486
|
|
|
(2,000
|
)
|
||
Net increase in cash and cash equivalents
|
|
108,472
|
|
|
145,968
|
|
||
Cash and cash equivalents at beginning of period
|
|
662,525
|
|
|
880,601
|
|
||
Cash and cash equivalents at end of period
|
|
$
|
770,997
|
|
|
$
|
1,026,569
|
|
|
June 30,
2016 |
|
December 31,
2015 |
||||
Current
|
$
|
352,021
|
|
|
$
|
520,144
|
|
Non-current
|
109,337
|
|
|
48,081
|
|
||
Total available-for-sale securities
|
$
|
461,358
|
|
|
$
|
568,225
|
|
|
|
June 30, 2016
|
||||||||||||||
|
|
Cost
|
|
Gross
Unrealized Gains |
|
Gross
Unrealized Losses (1) |
|
Fair Value
|
||||||||
Debt securities
|
|
|
|
|
|
|
|
|
||||||||
Corporate bonds
|
|
$
|
219,971
|
|
|
$
|
1,162
|
|
|
$
|
(16
|
)
|
|
$
|
221,117
|
|
U.S. government debt
(2)
|
|
72,702
|
|
|
462
|
|
|
—
|
|
|
73,164
|
|
||||
Asset-backed securities
|
|
57,546
|
|
|
197
|
|
|
(3
|
)
|
|
57,740
|
|
||||
Equity securities
|
|
60,281
|
|
|
49,194
|
|
|
(138
|
)
|
|
109,337
|
|
||||
Total available-for-sale securities
|
|
$
|
410,500
|
|
|
$
|
51,015
|
|
|
$
|
(157
|
)
|
|
$
|
461,358
|
|
|
|
December 31, 2015
|
||||||||||||||
|
|
Cost
|
|
Gross
Unrealized Gains |
|
Gross
Unrealized Losses (1) |
|
Fair Value
|
||||||||
Debt securities
|
|
|
|
|
|
|
|
|
||||||||
Corporate bonds
|
|
$
|
336,665
|
|
|
$
|
55
|
|
|
$
|
(1,076
|
)
|
|
$
|
335,644
|
|
U.S. government debt
(2)
|
|
135,226
|
|
|
2
|
|
|
(374
|
)
|
|
134,854
|
|
||||
Asset-backed securities
|
|
49,759
|
|
|
2
|
|
|
(115
|
)
|
|
49,646
|
|
||||
Equity securities
|
|
54,371
|
|
|
466
|
|
|
(6,756
|
)
|
|
48,081
|
|
||||
Total available-for-sale securities
|
|
$
|
576,021
|
|
|
$
|
525
|
|
|
$
|
(8,321
|
)
|
|
$
|
568,225
|
|
(1)
|
All unrealized loss positions were held at a loss for less than 12 months.
|
(2)
|
U.S. Treasury obligations, U.S. government agency obligations and U.S government agency mortgage-backed securities.
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Proceeds from sales and maturities of securities
|
|
$
|
275,573
|
|
|
$
|
15,037
|
|
|
$
|
302,432
|
|
|
$
|
15,037
|
|
Gross realized gains
|
|
1,280
|
|
|
3,795
|
|
|
1,341
|
|
|
3,795
|
|
||||
Gross realized losses
|
|
(13
|
)
|
|
—
|
|
|
(22
|
)
|
|
—
|
|
|
|
June 30,
2016 |
|
December 31,
2015 |
||||
Trade customers
|
|
$
|
507,690
|
|
|
$
|
438,538
|
|
Allowance for doubtful accounts
|
|
(14,534
|
)
|
|
(14,095
|
)
|
||
|
|
493,156
|
|
|
424,443
|
|
||
Federal and state taxes
|
|
69,183
|
|
|
60,748
|
|
||
Other
|
|
20,516
|
|
|
23,341
|
|
||
Accounts receivable, net
|
|
$
|
582,855
|
|
|
$
|
508,532
|
|
|
|
June 30,
2016 |
|
December 31,
2015 |
||||
Finished products
|
|
$
|
253,828
|
|
|
$
|
253,338
|
|
Feedstock, additives and chemicals
|
|
118,262
|
|
|
106,435
|
|
||
Materials and supplies
|
|
76,436
|
|
|
74,287
|
|
||
Inventories
|
|
$
|
448,526
|
|
|
$
|
434,060
|
|
|
|
June 30,
2016 |
|
December 31,
2015 |
||||
Accounts payable
|
|
$
|
305,853
|
|
|
$
|
229,219
|
|
Notes payable to banks
|
|
1,263
|
|
|
6,110
|
|
||
Accounts and notes payable
|
|
$
|
307,116
|
|
|
$
|
235,329
|
|
|
|
June 30, 2016
|
|
December 31, 2015
|
||||||||||||||||||||
|
|
Principal
Amount |
|
Unamortized
Discount and Debt Issuance Costs |
|
Net
Long-term Debt |
|
Principal
Amount |
|
Unamortized
Discount and Debt Issuance Costs |
|
Net
Long-term Debt |
||||||||||||
3.60% senior notes due 2022
|
|
$
|
250,000
|
|
|
$
|
(2,061
|
)
|
|
$
|
247,939
|
|
|
$
|
250,000
|
|
|
$
|
(2,232
|
)
|
|
$
|
247,768
|
|
6 ½% senior notes due 2029
|
|
100,000
|
|
|
(952
|
)
|
|
99,048
|
|
|
100,000
|
|
|
(989
|
)
|
|
99,011
|
|
||||||
6 ¾% senior notes due 2032
|
|
250,000
|
|
|
(1,943
|
)
|
|
248,057
|
|
|
250,000
|
|
|
(2,002
|
)
|
|
247,998
|
|
||||||
6 ½% senior notes due 2035 (the "6 ½%
GO Zone Senior Notes Due 2035")
|
|
89,000
|
|
|
(862
|
)
|
|
88,138
|
|
|
89,000
|
|
|
(884
|
)
|
|
88,116
|
|
||||||
6 ½% senior notes due 2035 (the "6 ½%
IKE Zone Senior Notes Due 2035")
|
|
65,000
|
|
|
(618
|
)
|
|
64,382
|
|
|
65,000
|
|
|
(634
|
)
|
|
64,366
|
|
||||||
Loan related to tax-exempt waste disposal
revenue bonds due 2027
|
|
10,889
|
|
|
—
|
|
|
10,889
|
|
|
10,889
|
|
|
—
|
|
|
10,889
|
|
||||||
Long-term debt, net
|
|
$
|
764,889
|
|
|
$
|
(6,436
|
)
|
|
$
|
758,453
|
|
|
$
|
764,889
|
|
|
$
|
(6,741
|
)
|
|
$
|
758,148
|
|
|
|
Common
Stock
|
|
Common
Stock,
Held in
Treasury
|
|
Additional
Paid-in
Capital
|
|
Retained
Earnings
|
|
Accumulated
Other
Comprehensive
Income (Loss)
|
|
Noncontrolling
Interests
|
|
Total
|
||||||||||||||
Balances at December 31, 2015
|
|
$
|
1,347
|
|
|
$
|
(258,312
|
)
|
|
$
|
542,148
|
|
|
$
|
3,109,987
|
|
|
$
|
(129,292
|
)
|
|
$
|
296,053
|
|
|
$
|
3,561,931
|
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
234,252
|
|
|
—
|
|
|
10,304
|
|
|
244,556
|
|
|||||||
Other comprehensive income,
net of income taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Pension and other post-
retirement benefits
liability
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
306
|
|
|
—
|
|
|
306
|
|
|||||||
Foreign currency
translation adjustments
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,305
|
|
|
—
|
|
|
9,305
|
|
|||||||
Net unrealized holding
gains on investments
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
37,580
|
|
|
—
|
|
|
37,580
|
|
|||||||
Common stock repurchased
|
|
—
|
|
|
(66,725
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(66,725
|
)
|
|||||||
Shares issued—stock-
based compensation
|
|
—
|
|
|
2,235
|
|
|
(1,754
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
481
|
|
|||||||
Stock-based compensation,
net of tax on stock options
exercised
|
|
—
|
|
|
—
|
|
|
5,403
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,403
|
|
|||||||
Dividends paid
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(47,317
|
)
|
|
—
|
|
|
—
|
|
|
(47,317
|
)
|
|||||||
Distributions to noncontrolling
interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(8,084
|
)
|
|
(8,084
|
)
|
|||||||
Balances at June 30, 2016
|
|
$
|
1,347
|
|
|
$
|
(322,802
|
)
|
|
$
|
545,797
|
|
|
$
|
3,296,922
|
|
|
$
|
(82,101
|
)
|
|
$
|
298,273
|
|
|
$
|
3,737,436
|
|
|
|
Common
Stock
|
|
Common
Stock,
Held in
Treasury
|
|
Additional
Paid-in
Capital
|
|
Retained
Earnings
|
|
Accumulated
Other
Comprehensive
Income (Loss)
|
|
Noncontrolling
Interests
|
|
Total
|
||||||||||||||
Balances at December 31, 2014
|
|
$
|
1,347
|
|
|
$
|
(96,372
|
)
|
|
$
|
530,441
|
|
|
$
|
2,555,528
|
|
|
$
|
(79,433
|
)
|
|
$
|
290,377
|
|
|
$
|
3,201,888
|
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
351,437
|
|
|
—
|
|
|
9,031
|
|
|
360,468
|
|
|||||||
Other comprehensive income
(loss), net of income taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Pension and other post-
retirement benefits
liability
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
752
|
|
|
—
|
|
|
752
|
|
|||||||
Foreign currency
translation adjustments
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(41,826
|
)
|
|
—
|
|
|
(41,826
|
)
|
|||||||
Net unrealized holding
gains on investments
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
583
|
|
|
—
|
|
|
583
|
|
|||||||
Common stock repurchased
|
|
—
|
|
|
(62,804
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(62,804
|
)
|
|||||||
Shares issued—stock-
based compensation
|
|
—
|
|
|
704
|
|
|
127
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
831
|
|
|||||||
Stock-based compensation,
net of tax on stock options
exercised
|
|
—
|
|
|
—
|
|
|
6,800
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,800
|
|
|||||||
Dividends paid
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(43,896
|
)
|
|
—
|
|
|
—
|
|
|
(43,896
|
)
|
|||||||
Distributions to noncontrolling
interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(7,218
|
)
|
|
(7,218
|
)
|
|||||||
Noncontrolling interest in
acquired business
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,597
|
|
|
1,597
|
|
|||||||
Balances at June 30, 2015
|
|
$
|
1,347
|
|
|
$
|
(158,472
|
)
|
|
$
|
537,368
|
|
|
$
|
2,863,069
|
|
|
$
|
(119,924
|
)
|
|
$
|
293,787
|
|
|
$
|
3,417,175
|
|
|
|
Benefits
Liability,
Net of Tax
|
|
Cumulative
Foreign
Currency
Exchange
|
|
Net Unrealized
Holding Gains
(Losses) on
Investments,
Net of Tax
|
|
Total
|
||||||||
Balances at December 31, 2015
|
|
$
|
(8,607
|
)
|
|
$
|
(115,690
|
)
|
|
$
|
(4,995
|
)
|
|
$
|
(129,292
|
)
|
Other comprehensive (loss) income before
reclassifications
|
|
(127
|
)
|
|
9,305
|
|
|
38,425
|
|
|
47,603
|
|
||||
Amounts reclassified from accumulated other
comprehensive loss (income)
|
|
433
|
|
|
—
|
|
|
(845
|
)
|
|
(412
|
)
|
||||
Net other comprehensive income for the period
|
|
306
|
|
|
9,305
|
|
|
37,580
|
|
|
47,191
|
|
||||
Balances at June 30, 2016
|
|
$
|
(8,301
|
)
|
|
$
|
(106,385
|
)
|
|
$
|
32,585
|
|
|
$
|
(82,101
|
)
|
|
|
Benefits
Liability,
Net of Tax
|
|
Cumulative
Foreign
Currency
Exchange
|
|
Net Unrealized
Holding Gains
on Investments,
Net of Tax
|
|
Total
|
||||||||
Balances at December 31, 2014
|
|
$
|
(23,442
|
)
|
|
$
|
(56,224
|
)
|
|
$
|
233
|
|
|
$
|
(79,433
|
)
|
Other comprehensive (loss) income before
reclassifications
|
|
(115
|
)
|
|
(41,826
|
)
|
|
3,015
|
|
|
(38,926
|
)
|
||||
Amounts reclassified from accumulated other
comprehensive loss (income)
|
|
867
|
|
|
—
|
|
|
(2,432
|
)
|
|
(1,565
|
)
|
||||
Net other comprehensive income (loss) for the period
|
|
752
|
|
|
(41,826
|
)
|
|
583
|
|
|
(40,491
|
)
|
||||
Balances at June 30, 2015
|
|
$
|
(22,690
|
)
|
|
$
|
(98,050
|
)
|
|
$
|
816
|
|
|
$
|
(119,924
|
)
|
Details about Accumulated
Other Comprehensive
Income (Loss) Components
|
|
Location of Reclassification
(Income (Expense)) in
Consolidated Statements
of Operations
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
|||||||||||
Amortization of pension and
other post-retirement items
|
|
|
|
|
|
|
|
|
|
|
||||||||
Net loss
|
|
(1)
|
|
$
|
(369
|
)
|
|
$
|
(675
|
)
|
|
$
|
(703
|
)
|
|
$
|
(1,327
|
)
|
|
|
Provision for
income taxes
|
|
142
|
|
|
235
|
|
|
270
|
|
|
460
|
|
||||
|
|
|
|
(227
|
)
|
|
(440
|
)
|
|
(433
|
)
|
|
(867
|
)
|
||||
Net unrealized gains on
available-for-sale
investments
|
|
|
|
|
|
|
|
|
|
|
||||||||
Realized gain on
available-for-sale
investments
|
|
Other income, net
|
|
1,267
|
|
|
3,795
|
|
|
1,319
|
|
|
3,795
|
|
||||
|
|
Provision for
income taxes
|
|
(455
|
)
|
|
(1,363
|
)
|
|
(474
|
)
|
|
(1,363
|
)
|
||||
|
|
|
|
812
|
|
|
2,432
|
|
|
845
|
|
|
2,432
|
|
||||
Total reclassifications for
the period
|
|
|
|
$
|
585
|
|
|
$
|
1,992
|
|
|
$
|
412
|
|
|
$
|
1,565
|
|
(1)
|
These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost. For additional information, please read Note 11 (Employee Benefits) to the financial statements included in the
2015
Form 10-K.
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||||||||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||||||||||||||||||
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
||||||||||||||||
Service cost
|
|
$
|
—
|
|
|
$
|
137
|
|
|
$
|
1
|
|
|
$
|
414
|
|
|
$
|
—
|
|
|
$
|
462
|
|
|
$
|
29
|
|
|
$
|
835
|
|
Interest cost
|
|
493
|
|
|
582
|
|
|
489
|
|
|
525
|
|
|
1,060
|
|
|
1,149
|
|
|
1,032
|
|
|
1,061
|
|
||||||||
Expected return on plan assets
|
|
(658
|
)
|
|
—
|
|
|
(705
|
)
|
|
—
|
|
|
(1,460
|
)
|
|
—
|
|
|
(1,524
|
)
|
|
—
|
|
||||||||
Amortization of net loss
|
|
337
|
|
|
—
|
|
|
318
|
|
|
261
|
|
|
640
|
|
|
—
|
|
|
609
|
|
|
526
|
|
||||||||
Net periodic benefit cost
|
|
$
|
172
|
|
|
$
|
719
|
|
|
$
|
103
|
|
|
$
|
1,200
|
|
|
$
|
240
|
|
|
$
|
1,611
|
|
|
$
|
146
|
|
|
$
|
2,422
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
|
U.S. Plans
|
|
U.S. Plans
|
|
U.S. Plans
|
|
U.S. Plans
|
||||||||
Service cost
|
|
$
|
5
|
|
|
$
|
6
|
|
|
$
|
10
|
|
|
$
|
11
|
|
Interest cost
|
|
145
|
|
|
149
|
|
|
290
|
|
|
299
|
|
||||
Amortization of net loss
|
|
32
|
|
|
96
|
|
|
63
|
|
|
192
|
|
||||
Net periodic benefit cost
|
|
$
|
182
|
|
|
$
|
251
|
|
|
$
|
363
|
|
|
$
|
502
|
|
|
|
Derivative Assets
|
||||||||
|
|
Balance Sheet Location
|
|
Fair Value as of
|
||||||
|
|
June 30,
2016 |
|
December 31,
2015 |
||||||
Not designated as hedging instruments
|
|
|
|
|
|
|
||||
Commodity forward contracts
|
|
Accounts receivable, net
|
|
$
|
4,491
|
|
|
$
|
3,465
|
|
Commodity forward contracts
|
|
Deferred charges and
other assets, net
|
|
5,517
|
|
|
2,088
|
|
||
Total derivative assets
|
|
|
|
$
|
10,008
|
|
|
$
|
5,553
|
|
|
|
Derivative Liabilities
|
||||||||
|
|
Balance Sheet Location
|
|
Fair Value as of
|
||||||
|
|
June 30,
2016 |
|
December 31,
2015 |
||||||
Not designated as hedging instruments
|
|
|
|
|
|
|
||||
Commodity forward contracts
|
|
Accrued liabilities
|
|
$
|
2,215
|
|
|
$
|
9,325
|
|
Commodity forward contracts
|
|
Other liabilities
|
|
5,506
|
|
|
12,437
|
|
||
Total derivative liabilities
|
|
|
|
$
|
7,721
|
|
|
$
|
21,762
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives Not Designated as
Hedging Instruments
|
|
Location of Gain (Loss) Recognized
in Income on Derivative
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||||||
Commodity forward contracts
|
|
Gross profit
|
|
$
|
11,567
|
|
|
$
|
595
|
|
|
$
|
15,624
|
|
|
$
|
4,836
|
|
|
|
Derivative Assets as of
|
||||||
|
|
June 30,
2016 |
|
December 31,
2015 |
||||
Derivative assets subject to enforceable master netting arrangements
|
|
$
|
504
|
|
|
$
|
—
|
|
Derivative assets not subject to enforceable master netting arrangements
|
|
5,773
|
|
|
462
|
|
||
Total derivative assets
|
|
$
|
6,277
|
|
|
$
|
462
|
|
|
|
June 30, 2016
|
|
December 31, 2015
|
||||||||||||||||||||
Offsetting of Derivative Assets
|
|
Gross Amounts of
Recognized Assets
|
|
Gross Amounts Offset in the
Consolidated Balance Sheet
|
|
Net Amounts of Assets Presented
in the Consolidated Balance Sheet
|
|
Gross Amounts of
Recognized Assets
|
|
Gross Amounts Offset in the
Consolidated Balance Sheet
|
|
Net Amounts of Assets Presented
in the Consolidated Balance Sheet
|
||||||||||||
Commodity forward contracts
|
|
$
|
4,235
|
|
|
$
|
(3,731
|
)
|
|
$
|
504
|
|
|
$
|
5,091
|
|
|
$
|
(5,091
|
)
|
|
$
|
—
|
|
|
|
June 30, 2016
|
|
December 31, 2015
|
||||||||||||||||||||
Derivative Assets by Counterparty
|
|
Net Amounts of Assets Presented
in the Consolidated Balance Sheet
|
|
Gross Amounts Not Offset in the
Consolidated Balance Sheet
|
|
Net
Amount
|
|
Net Amounts of Assets Presented
in the Consolidated Balance Sheet
|
|
Gross Amounts Not Offset in the
Consolidated Balance Sheet
|
|
Net
Amount
|
||||||||||||
Counterparty A
|
|
$
|
414
|
|
|
$
|
—
|
|
|
$
|
414
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Counterparty B
|
|
90
|
|
|
—
|
|
|
90
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Total
|
|
$
|
504
|
|
|
$
|
—
|
|
|
$
|
504
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
Derivative Liabilities as of
|
||||||
|
|
June 30,
2016 |
|
December 31,
2015 |
||||
Derivative liabilities subject to enforceable master netting arrangements
|
|
$
|
290
|
|
|
$
|
5,803
|
|
Derivative liabilities not subject to enforceable master netting arrangements
|
|
3,700
|
|
|
10,868
|
|
||
Total derivative liabilities
|
|
$
|
3,990
|
|
|
$
|
16,671
|
|
|
|
June 30, 2016
|
|
December 31, 2015
|
||||||||||||||||||||
Offsetting of Derivative Liabilities
|
|
Gross Amounts of
Recognized Liabilities
|
|
Gross Amounts Offset in the
Consolidated Balance Sheet
|
|
Net Amounts of Liabilities Presented
in the Consolidated Balance Sheet
|
|
Gross Amounts of
Recognized Liabilities
|
|
Gross Amounts Offset in the
Consolidated Balance Sheet
|
|
Net Amounts of Liabilities Presented
in the Consolidated Balance Sheet
|
||||||||||||
Commodity forward contracts
|
|
$
|
4,021
|
|
|
$
|
(3,731
|
)
|
|
$
|
290
|
|
|
$
|
10,894
|
|
|
$
|
(5,091
|
)
|
|
$
|
5,803
|
|
|
|
June 30, 2016
|
|
December 31, 2015
|
||||||||||||||||||||
Derivative Liabilities by Counterparty
|
|
Net Amounts of Liabilities Presented
in the Consolidated Balance Sheet
|
|
Gross Amounts Not Offset in the
Consolidated Balance Sheet
|
|
Net
Amount
|
|
Net Amounts of Liabilities Presented
in the Consolidated Balance Sheet
|
|
Gross Amounts Not Offset in the
Consolidated Balance Sheet
|
|
Net
Amount
|
||||||||||||
Counterparty A
|
|
$
|
290
|
|
|
$
|
—
|
|
|
$
|
290
|
|
|
$
|
5,564
|
|
|
$
|
—
|
|
|
$
|
5,564
|
|
Counterparty B
|
|
—
|
|
|
—
|
|
|
—
|
|
|
239
|
|
|
—
|
|
|
239
|
|
||||||
Total
|
|
$
|
290
|
|
|
$
|
—
|
|
|
$
|
290
|
|
|
$
|
5,803
|
|
|
$
|
—
|
|
|
$
|
5,803
|
|
|
|
June 30, 2016
|
||||||||||
|
|
Level 1
|
|
Level 2
|
|
Total
|
||||||
Derivative instruments
|
|
|
|
|
|
|
||||||
Risk management assets—Commodity forward contracts
|
|
$
|
1,607
|
|
|
$
|
8,401
|
|
|
$
|
10,008
|
|
Risk management liabilities—Commodity forward contracts
|
|
(7,348
|
)
|
|
(373
|
)
|
|
(7,721
|
)
|
|||
Marketable securities
|
|
|
|
|
|
|
||||||
Available-for-sale securities
|
|
109,337
|
|
|
352,021
|
|
|
461,358
|
|
|||
|
|
|
|
|
|
|
||||||
|
|
December 31, 2015
|
||||||||||
|
|
Level 1
|
|
Level 2
|
|
Total
|
||||||
Derivative instruments
|
|
|
|
|
|
|
||||||
Risk management assets—Commodity forward contracts
|
|
$
|
5,553
|
|
|
$
|
—
|
|
|
$
|
5,553
|
|
Risk management liabilities—Commodity forward contracts
|
|
(11,648
|
)
|
|
(10,114
|
)
|
|
(21,762
|
)
|
|||
Marketable securities
|
|
|
|
|
|
|
||||||
Available-for-sale securities
|
|
48,081
|
|
|
520,144
|
|
|
568,225
|
|
|
|
June 30, 2016
|
|
December 31, 2015
|
||||||||||||
|
|
Carrying
Value
|
|
Fair
Value
|
|
Carrying
Value
|
|
Fair
Value
|
||||||||
3.60% senior notes due 2022
|
|
$
|
247,939
|
|
|
$
|
251,523
|
|
|
$
|
247,768
|
|
|
$
|
244,828
|
|
6 ½% senior notes due 2029
|
|
99,048
|
|
|
120,125
|
|
|
99,011
|
|
|
117,153
|
|
||||
6 ¾% senior notes due 2032
|
|
248,057
|
|
|
268,790
|
|
|
247,998
|
|
|
268,490
|
|
||||
6 ½% GO Zone Senior Notes Due 2035
|
|
88,138
|
|
|
107,025
|
|
|
88,116
|
|
|
106,491
|
|
||||
6 ½% IKE Zone Senior Notes Due 2035
|
|
64,382
|
|
|
78,127
|
|
|
64,366
|
|
|
76,741
|
|
||||
Loan related to tax-exempt waste disposal revenue
bonds due 2027
|
|
10,889
|
|
|
10,889
|
|
|
10,889
|
|
|
10,889
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Net income attributable to
Westlake Chemical Corporation
|
|
$
|
111,124
|
|
|
$
|
205,095
|
|
|
$
|
234,252
|
|
|
$
|
351,437
|
|
Less:
|
|
|
|
|
|
|
|
|
||||||||
Net income attributable to participating securities
|
|
(504
|
)
|
|
(253
|
)
|
|
(1,054
|
)
|
|
(457
|
)
|
||||
Net income attributable to common shareholders
|
|
$
|
110,620
|
|
|
$
|
204,842
|
|
|
$
|
233,198
|
|
|
$
|
350,980
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Weighted average common shares—basic
|
|
129,583,224
|
|
|
132,538,123
|
|
|
129,886,594
|
|
|
132,625,857
|
|
||||
Plus incremental shares from:
|
|
|
|
|
|
|
|
|
||||||||
Assumed exercise of options
|
|
397,303
|
|
|
506,852
|
|
|
403,927
|
|
|
498,840
|
|
||||
Weighted average common shares—diluted
|
|
129,980,527
|
|
|
133,044,975
|
|
|
130,290,521
|
|
|
133,124,697
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
Earnings per common share attributable to
Westlake Chemical Corporation:
|
|
|
|
|
|
|
|
|
||||||||
Basic
|
|
$
|
0.85
|
|
|
$
|
1.55
|
|
|
$
|
1.80
|
|
|
$
|
2.65
|
|
Diluted
|
|
$
|
0.85
|
|
|
$
|
1.54
|
|
|
$
|
1.79
|
|
|
$
|
2.64
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Interest income
|
|
$
|
3,084
|
|
|
$
|
866
|
|
|
$
|
6,363
|
|
|
$
|
1,751
|
|
Dividend income
|
|
3,845
|
|
|
1,357
|
|
|
4,274
|
|
|
3,329
|
|
||||
Foreign exchange currency gains (losses), net
|
|
400
|
|
|
(500
|
)
|
|
(1,154
|
)
|
|
1,871
|
|
||||
Income (loss) from equity method investments
|
|
988
|
|
|
(350
|
)
|
|
2,389
|
|
|
4,613
|
|
||||
Impairment of equity method investment
|
|
—
|
|
|
(4,925
|
)
|
|
—
|
|
|
(4,925
|
)
|
||||
Gain on acquisition and related expenses, net
|
|
—
|
|
|
20,430
|
|
|
—
|
|
|
20,430
|
|
||||
Gains from sales of securities, net
|
|
1,267
|
|
|
3,795
|
|
|
1,319
|
|
|
3,795
|
|
||||
Other
|
|
(1,403
|
)
|
|
1,385
|
|
|
(2,365
|
)
|
|
290
|
|
||||
Other income, net
|
|
$
|
8,181
|
|
|
$
|
22,058
|
|
|
$
|
10,826
|
|
|
$
|
31,154
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Net external sales
|
|
|
|
|
|
|
|
|
||||||||
Olefins
|
|
|
|
|
|
|
|
|
||||||||
Polyethylene
|
|
$
|
371,658
|
|
|
$
|
450,482
|
|
|
$
|
717,690
|
|
|
$
|
859,914
|
|
Styrene, feedstock and other
|
|
122,826
|
|
|
170,396
|
|
|
207,814
|
|
|
344,041
|
|
||||
Total Olefins
|
|
494,484
|
|
|
620,878
|
|
|
925,504
|
|
|
1,203,955
|
|
||||
Vinyls
|
|
|
|
|
|
|
|
|
||||||||
PVC, caustic soda and other
|
|
462,472
|
|
|
429,878
|
|
|
893,374
|
|
|
846,866
|
|
||||
Building products
|
|
129,105
|
|
|
134,246
|
|
|
242,370
|
|
|
237,712
|
|
||||
Total Vinyls
|
|
591,577
|
|
|
564,124
|
|
|
1,135,744
|
|
|
1,084,578
|
|
||||
|
|
$
|
1,086,061
|
|
|
$
|
1,185,002
|
|
|
$
|
2,061,248
|
|
|
$
|
2,288,533
|
|
|
|
|
|
|
|
|
|
|
||||||||
Intersegment sales
|
|
|
|
|
|
|
|
|
||||||||
Olefins
|
|
$
|
27,293
|
|
|
$
|
26,641
|
|
|
$
|
55,242
|
|
|
$
|
50,103
|
|
Vinyls
|
|
225
|
|
|
387
|
|
|
589
|
|
|
757
|
|
||||
|
|
$
|
27,518
|
|
|
$
|
27,028
|
|
|
$
|
55,831
|
|
|
$
|
50,860
|
|
|
|
|
|
|
|
|
|
|
||||||||
Income (loss) from operations
|
|
|
|
|
|
|
|
|
||||||||
Olefins
|
|
$
|
140,564
|
|
|
$
|
220,938
|
|
|
$
|
289,799
|
|
|
$
|
412,041
|
|
Vinyls
|
|
52,208
|
|
|
87,966
|
|
|
114,324
|
|
|
135,052
|
|
||||
Corporate and other
|
|
(12,834
|
)
|
|
(13,530
|
)
|
|
(21,909
|
)
|
|
(22,439
|
)
|
||||
|
|
$
|
179,938
|
|
|
$
|
295,374
|
|
|
$
|
382,214
|
|
|
$
|
524,654
|
|
|
|
|
|
|
|
|
|
|
||||||||
Depreciation and amortization
|
|
|
|
|
|
|
|
|
||||||||
Olefins
|
|
$
|
30,236
|
|
|
$
|
27,623
|
|
|
$
|
58,933
|
|
|
$
|
54,562
|
|
Vinyls
|
|
36,268
|
|
|
32,599
|
|
|
72,555
|
|
|
64,183
|
|
||||
Corporate and other
|
|
746
|
|
|
118
|
|
|
1,476
|
|
|
236
|
|
||||
|
|
$
|
67,250
|
|
|
$
|
60,340
|
|
|
$
|
132,964
|
|
|
$
|
118,981
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Other income (expense), net
|
|
|
|
|
|
|
|
|
||||||||
Olefins
|
|
$
|
1,093
|
|
|
$
|
(104
|
)
|
|
$
|
2,606
|
|
|
$
|
2,448
|
|
Vinyls
|
|
4,466
|
|
|
1,413
|
|
|
2,949
|
|
|
6,916
|
|
||||
Corporate and other
|
|
2,622
|
|
|
20,749
|
|
|
5,271
|
|
|
21,790
|
|
||||
|
|
$
|
8,181
|
|
|
$
|
22,058
|
|
|
$
|
10,826
|
|
|
$
|
31,154
|
|
|
|
|
|
|
|
|
|
|
||||||||
Provision for (benefit from) income taxes
|
|
|
|
|
|
|
|
|
||||||||
Olefins
|
|
$
|
51,940
|
|
|
$
|
74,212
|
|
|
$
|
104,473
|
|
|
$
|
140,669
|
|
Vinyls
|
|
16,297
|
|
|
26,653
|
|
|
33,567
|
|
|
39,458
|
|
||||
Corporate and other
|
|
(1,653
|
)
|
|
(2,452
|
)
|
|
(2,156
|
)
|
|
(3,336
|
)
|
||||
|
|
$
|
66,584
|
|
|
$
|
98,413
|
|
|
$
|
135,884
|
|
|
$
|
176,791
|
|
|
|
|
|
|
|
|
|
|
||||||||
Capital expenditures
|
|
|
|
|
|
|
|
|
||||||||
Olefins
|
|
$
|
93,739
|
|
|
$
|
81,534
|
|
|
$
|
188,890
|
|
|
$
|
136,835
|
|
Vinyls
|
|
56,613
|
|
|
24,569
|
|
|
96,869
|
|
|
61,425
|
|
||||
Corporate and other
|
|
481
|
|
|
2,007
|
|
|
1,401
|
|
|
5,673
|
|
||||
|
|
$
|
150,833
|
|
|
$
|
108,110
|
|
|
$
|
287,160
|
|
|
$
|
203,933
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Income from operations
|
|
$
|
179,938
|
|
|
$
|
295,374
|
|
|
$
|
382,214
|
|
|
$
|
524,654
|
|
Interest expense
|
|
(5,915
|
)
|
|
(8,958
|
)
|
|
(12,600
|
)
|
|
(18,549
|
)
|
||||
Other income, net
|
|
8,181
|
|
|
22,058
|
|
|
10,826
|
|
|
31,154
|
|
||||
Income before income taxes
|
|
$
|
182,204
|
|
|
$
|
308,474
|
|
|
$
|
380,440
|
|
|
$
|
537,259
|
|
|
|
June 30,
2016 |
|
December 31,
2015 |
||||
Total assets
|
|
|
|
|
||||
Olefins
|
|
$
|
2,130,028
|
|
|
$
|
1,869,888
|
|
Vinyls
|
|
2,734,246
|
|
|
2,638,833
|
|
||
Corporate and other
|
|
1,056,290
|
|
|
1,060,564
|
|
||
|
|
$
|
5,920,564
|
|
|
$
|
5,569,285
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
Balance Sheet
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Current assets
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Cash and cash equivalents
|
|
$
|
412,881
|
|
|
$
|
1,095
|
|
|
$
|
142,339
|
|
|
$
|
214,682
|
|
|
$
|
—
|
|
|
$
|
770,997
|
|
Marketable securities
|
|
352,021
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
352,021
|
|
||||||
Accounts receivable, net
|
|
15,228
|
|
|
2,306,348
|
|
|
68,738
|
|
|
136,839
|
|
|
(1,944,298
|
)
|
|
582,855
|
|
||||||
Inventories
|
|
—
|
|
|
348,372
|
|
|
2,493
|
|
|
97,661
|
|
|
—
|
|
|
448,526
|
|
||||||
Prepaid expenses and other current assets
|
|
11,126
|
|
|
15,861
|
|
|
73
|
|
|
12,820
|
|
|
(4,238
|
)
|
|
35,642
|
|
||||||
Total current assets
|
|
791,256
|
|
|
2,671,676
|
|
|
213,643
|
|
|
462,002
|
|
|
(1,948,536
|
)
|
|
2,190,041
|
|
||||||
Property, plant and equipment, net
|
|
—
|
|
|
1,606,327
|
|
|
1,203,249
|
|
|
420,947
|
|
|
—
|
|
|
3,230,523
|
|
||||||
Equity investments
|
|
5,269,364
|
|
|
1,211,547
|
|
|
—
|
|
|
471,900
|
|
|
(6,943,882
|
)
|
|
8,929
|
|
||||||
Other assets, net
|
|
59,169
|
|
|
587,816
|
|
|
126,424
|
|
|
129,944
|
|
|
(412,282
|
)
|
|
491,071
|
|
||||||
Total assets
|
|
$
|
6,119,789
|
|
|
$
|
6,077,366
|
|
|
$
|
1,543,316
|
|
|
$
|
1,484,793
|
|
|
$
|
(9,304,700
|
)
|
|
$
|
5,920,564
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Accounts and notes payable
|
|
$
|
1,924,189
|
|
|
$
|
116,376
|
|
|
$
|
93,294
|
|
|
$
|
91,435
|
|
|
$
|
(1,918,178
|
)
|
|
$
|
307,116
|
|
Accrued liabilities
|
|
8,873
|
|
|
164,520
|
|
|
75,405
|
|
|
94,545
|
|
|
(30,358
|
)
|
|
312,985
|
|
||||||
Total current liabilities
|
|
1,933,062
|
|
|
280,896
|
|
|
168,699
|
|
|
185,980
|
|
|
(1,948,536
|
)
|
|
620,101
|
|
||||||
Long-term debt
|
|
747,564
|
|
|
10,889
|
|
|
379,997
|
|
|
—
|
|
|
(379,997
|
)
|
|
758,453
|
|
||||||
Deferred income taxes
|
|
—
|
|
|
618,716
|
|
|
1,712
|
|
|
48,596
|
|
|
(4,037
|
)
|
|
664,987
|
|
||||||
Other liabilities
|
|
—
|
|
|
67,744
|
|
|
—
|
|
|
100,091
|
|
|
(28,248
|
)
|
|
139,587
|
|
||||||
Total liabilities
|
|
2,680,626
|
|
|
978,245
|
|
|
550,408
|
|
|
334,667
|
|
|
(2,360,818
|
)
|
|
2,183,128
|
|
||||||
Total Westlake Chemical Corporation stockholders' equity
|
|
3,439,163
|
|
|
5,099,121
|
|
|
992,908
|
|
|
851,853
|
|
|
(6,943,882
|
)
|
|
3,439,163
|
|
||||||
Noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
298,273
|
|
|
—
|
|
|
298,273
|
|
||||||
Total equity
|
|
3,439,163
|
|
|
5,099,121
|
|
|
992,908
|
|
|
1,150,126
|
|
|
(6,943,882
|
)
|
|
3,737,436
|
|
||||||
Total liabilities and equity
|
|
$
|
6,119,789
|
|
|
$
|
6,077,366
|
|
|
$
|
1,543,316
|
|
|
$
|
1,484,793
|
|
|
$
|
(9,304,700
|
)
|
|
$
|
5,920,564
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
Balance Sheet
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Current assets
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Cash and cash equivalents
|
|
$
|
303,131
|
|
|
$
|
6,828
|
|
|
$
|
163,430
|
|
|
$
|
189,136
|
|
|
$
|
—
|
|
|
$
|
662,525
|
|
Marketable securities
|
|
520,144
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
520,144
|
|
||||||
Accounts receivable, net
|
|
10,943
|
|
|
2,183,276
|
|
|
51,582
|
|
|
113,321
|
|
|
(1,850,590
|
)
|
|
508,532
|
|
||||||
Inventories
|
|
—
|
|
|
326,588
|
|
|
3,879
|
|
|
103,593
|
|
|
—
|
|
|
434,060
|
|
||||||
Prepaid expenses and other current assets
|
|
2,201
|
|
|
12,166
|
|
|
267
|
|
|
2,734
|
|
|
(2,879
|
)
|
|
14,489
|
|
||||||
Deferred income taxes
|
|
702
|
|
|
32,787
|
|
|
—
|
|
|
1,950
|
|
|
—
|
|
|
35,439
|
|
||||||
Total current assets
|
|
837,121
|
|
|
2,561,645
|
|
|
219,158
|
|
|
410,734
|
|
|
(1,853,469
|
)
|
|
2,175,189
|
|
||||||
Property, plant and equipment, net
|
|
—
|
|
|
1,567,897
|
|
|
1,020,469
|
|
|
415,701
|
|
|
—
|
|
|
3,004,067
|
|
||||||
Equity investments
|
|
4,991,167
|
|
|
1,207,679
|
|
|
—
|
|
|
469,915
|
|
|
(6,659,553
|
)
|
|
9,208
|
|
||||||
Other assets, net
|
|
11,929
|
|
|
450,428
|
|
|
44,157
|
|
|
129,539
|
|
|
(255,232
|
)
|
|
380,821
|
|
||||||
Total assets
|
|
$
|
5,840,217
|
|
|
$
|
5,787,649
|
|
|
$
|
1,283,784
|
|
|
$
|
1,425,889
|
|
|
$
|
(8,768,254
|
)
|
|
$
|
5,569,285
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Accounts payable
|
|
$
|
1,817,963
|
|
|
$
|
121,820
|
|
|
$
|
33,901
|
|
|
$
|
87,510
|
|
|
$
|
(1,825,865
|
)
|
|
$
|
235,329
|
|
Accrued liabilities
|
|
9,117
|
|
|
195,785
|
|
|
21,873
|
|
|
88,142
|
|
|
(27,604
|
)
|
|
287,313
|
|
||||||
Total current liabilities
|
|
1,827,080
|
|
|
317,605
|
|
|
55,774
|
|
|
175,652
|
|
|
(1,853,469
|
)
|
|
522,642
|
|
||||||
Long-term debt
|
|
747,259
|
|
|
10,889
|
|
|
248,665
|
|
|
—
|
|
|
(248,665
|
)
|
|
758,148
|
|
||||||
Deferred income taxes
|
|
—
|
|
|
532,837
|
|
|
1,392
|
|
|
47,941
|
|
|
(6,567
|
)
|
|
575,603
|
|
||||||
Other liabilities
|
|
—
|
|
|
49,334
|
|
|
—
|
|
|
101,627
|
|
|
—
|
|
|
150,961
|
|
||||||
Total liabilities
|
|
2,574,339
|
|
|
910,665
|
|
|
305,831
|
|
|
325,220
|
|
|
(2,108,701
|
)
|
|
2,007,354
|
|
||||||
Total Westlake Chemical Corporation stockholders' equity
|
|
3,265,878
|
|
|
4,876,984
|
|
|
977,953
|
|
|
804,616
|
|
|
(6,659,553
|
)
|
|
3,265,878
|
|
||||||
Noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
296,053
|
|
|
—
|
|
|
296,053
|
|
||||||
Total equity
|
|
3,265,878
|
|
|
4,876,984
|
|
|
977,953
|
|
|
1,100,669
|
|
|
(6,659,553
|
)
|
|
3,561,931
|
|
||||||
Total liabilities and equity
|
|
$
|
5,840,217
|
|
|
$
|
5,787,649
|
|
|
$
|
1,283,784
|
|
|
$
|
1,425,889
|
|
|
$
|
(8,768,254
|
)
|
|
$
|
5,569,285
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net sales
|
|
$
|
—
|
|
|
$
|
845,088
|
|
|
$
|
210,841
|
|
|
$
|
289,520
|
|
|
$
|
(259,388
|
)
|
|
$
|
1,086,061
|
|
Cost of sales
|
|
—
|
|
|
720,774
|
|
|
122,460
|
|
|
255,846
|
|
|
(254,385
|
)
|
|
844,695
|
|
||||||
Gross profit
|
|
—
|
|
|
124,314
|
|
|
88,381
|
|
|
33,674
|
|
|
(5,003
|
)
|
|
241,366
|
|
||||||
Selling, general and administrative expenses
|
|
950
|
|
|
48,331
|
|
|
5,174
|
|
|
11,976
|
|
|
(5,003
|
)
|
|
61,428
|
|
||||||
(Loss) income from operations
|
|
(950
|
)
|
|
75,983
|
|
|
83,207
|
|
|
21,698
|
|
|
—
|
|
|
179,938
|
|
||||||
Interest expense
|
|
(10,688
|
)
|
|
(13
|
)
|
|
(221
|
)
|
|
(50
|
)
|
|
5,057
|
|
|
(5,915
|
)
|
||||||
Other income, net
|
|
3,587
|
|
|
4,900
|
|
|
159
|
|
|
4,592
|
|
|
(5,057
|
)
|
|
8,181
|
|
||||||
(Loss) income before income taxes
|
|
(8,051
|
)
|
|
80,870
|
|
|
83,145
|
|
|
26,240
|
|
|
—
|
|
|
182,204
|
|
||||||
(Benefit from) provision for income taxes
|
|
(2,960
|
)
|
|
62,396
|
|
|
297
|
|
|
6,851
|
|
|
—
|
|
|
66,584
|
|
||||||
Equity in net income of subsidiaries
|
|
116,215
|
|
|
71,849
|
|
|
—
|
|
|
10,999
|
|
|
(199,063
|
)
|
|
—
|
|
||||||
Net income
|
|
111,124
|
|
|
90,323
|
|
|
82,848
|
|
|
30,388
|
|
|
(199,063
|
)
|
|
115,620
|
|
||||||
Net income attributable to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,496
|
|
|
—
|
|
|
4,496
|
|
||||||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
111,124
|
|
|
$
|
90,323
|
|
|
$
|
82,848
|
|
|
$
|
25,892
|
|
|
$
|
(199,063
|
)
|
|
$
|
111,124
|
|
Comprehensive income attributable to
Westlake Chemical Corporation
|
|
$
|
119,686
|
|
|
$
|
102,001
|
|
|
$
|
82,848
|
|
|
$
|
12,392
|
|
|
$
|
(197,241
|
)
|
|
$
|
119,686
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net sales
|
|
$
|
—
|
|
|
$
|
990,434
|
|
|
$
|
251,705
|
|
|
$
|
250,365
|
|
|
$
|
(307,502
|
)
|
|
$
|
1,185,002
|
|
Cost of sales
|
|
—
|
|
|
750,892
|
|
|
157,177
|
|
|
226,283
|
|
|
(302,531
|
)
|
|
831,821
|
|
||||||
Gross profit
|
|
—
|
|
|
239,542
|
|
|
94,528
|
|
|
24,082
|
|
|
(4,971
|
)
|
|
353,181
|
|
||||||
Selling, general and administrative expenses
|
|
399
|
|
|
42,682
|
|
|
5,191
|
|
|
14,506
|
|
|
(4,971
|
)
|
|
57,807
|
|
||||||
(Loss) income from operations
|
|
(399
|
)
|
|
196,860
|
|
|
89,337
|
|
|
9,576
|
|
|
—
|
|
|
295,374
|
|
||||||
Interest expense
|
|
(10,569
|
)
|
|
(4
|
)
|
|
(856
|
)
|
|
(52
|
)
|
|
2,523
|
|
|
(8,958
|
)
|
||||||
Other income (expense), net
|
|
9,776
|
|
|
(9,371
|
)
|
|
34
|
|
|
24,142
|
|
|
(2,523
|
)
|
|
22,058
|
|
||||||
(Loss) income before income taxes
|
|
(1,192
|
)
|
|
187,485
|
|
|
88,515
|
|
|
33,666
|
|
|
—
|
|
|
308,474
|
|
||||||
(Benefit from) provision for income taxes
|
|
(399
|
)
|
|
97,218
|
|
|
(41
|
)
|
|
1,635
|
|
|
—
|
|
|
98,413
|
|
||||||
Equity in net income of subsidiaries
|
|
205,888
|
|
|
76,799
|
|
|
—
|
|
|
11,757
|
|
|
(294,444
|
)
|
|
—
|
|
||||||
Net income
|
|
205,095
|
|
|
167,066
|
|
|
88,556
|
|
|
43,788
|
|
|
(294,444
|
)
|
|
210,061
|
|
||||||
Net income attributable to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,966
|
|
|
—
|
|
|
4,966
|
|
||||||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
205,095
|
|
|
$
|
167,066
|
|
|
$
|
88,556
|
|
|
$
|
38,822
|
|
|
$
|
(294,444
|
)
|
|
$
|
205,095
|
|
Comprehensive income attributable to
Westlake Chemical Corporation
|
|
$
|
222,833
|
|
|
$
|
167,206
|
|
|
$
|
88,556
|
|
|
$
|
56,879
|
|
|
$
|
(312,641
|
)
|
|
$
|
222,833
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net sales
|
|
$
|
—
|
|
|
$
|
1,629,152
|
|
|
$
|
463,445
|
|
|
$
|
552,434
|
|
|
$
|
(583,783
|
)
|
|
$
|
2,061,248
|
|
Cost of sales
|
|
—
|
|
|
1,386,241
|
|
|
264,650
|
|
|
486,718
|
|
|
(573,312
|
)
|
|
1,564,297
|
|
||||||
Gross profit
|
|
—
|
|
|
242,911
|
|
|
198,795
|
|
|
65,716
|
|
|
(10,471
|
)
|
|
496,951
|
|
||||||
Selling, general and administrative expenses
|
|
1,557
|
|
|
88,959
|
|
|
10,452
|
|
|
24,240
|
|
|
(10,471
|
)
|
|
114,737
|
|
||||||
(Loss) income from operations
|
|
(1,557
|
)
|
|
153,952
|
|
|
188,343
|
|
|
41,476
|
|
|
—
|
|
|
382,214
|
|
||||||
Interest expense
|
|
(21,099
|
)
|
|
(16
|
)
|
|
(472
|
)
|
|
(128
|
)
|
|
9,115
|
|
|
(12,600
|
)
|
||||||
Other income, net
|
|
5,402
|
|
|
11,343
|
|
|
243
|
|
|
2,953
|
|
|
(9,115
|
)
|
|
10,826
|
|
||||||
(Loss) income before income taxes
|
|
(17,254
|
)
|
|
165,279
|
|
|
188,114
|
|
|
44,301
|
|
|
—
|
|
|
380,440
|
|
||||||
(Benefit from) provision for income taxes
|
|
(6,182
|
)
|
|
129,252
|
|
|
696
|
|
|
12,118
|
|
|
—
|
|
|
135,884
|
|
||||||
Equity in net income of subsidiaries
|
|
245,324
|
|
|
162,536
|
|
|
—
|
|
|
24,882
|
|
|
(432,742
|
)
|
|
—
|
|
||||||
Net income
|
|
234,252
|
|
|
198,563
|
|
|
187,418
|
|
|
57,065
|
|
|
(432,742
|
)
|
|
244,556
|
|
||||||
Net income attributable to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
10,304
|
|
|
—
|
|
|
10,304
|
|
||||||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
234,252
|
|
|
$
|
198,563
|
|
|
$
|
187,418
|
|
|
$
|
46,761
|
|
|
$
|
(432,742
|
)
|
|
$
|
234,252
|
|
Comprehensive income attributable to
Westlake Chemical Corporation
|
|
$
|
281,443
|
|
|
$
|
222,127
|
|
|
$
|
187,418
|
|
|
$
|
56,066
|
|
|
$
|
(465,611
|
)
|
|
$
|
281,443
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net sales
|
|
$
|
—
|
|
|
$
|
1,901,365
|
|
|
$
|
510,096
|
|
|
$
|
496,007
|
|
|
$
|
(618,935
|
)
|
|
$
|
2,288,533
|
|
Cost of sales
|
|
—
|
|
|
1,485,728
|
|
|
319,341
|
|
|
454,553
|
|
|
(608,816
|
)
|
|
1,650,806
|
|
||||||
Gross profit
|
|
—
|
|
|
415,637
|
|
|
190,755
|
|
|
41,454
|
|
|
(10,119
|
)
|
|
637,727
|
|
||||||
Selling, general and administrative expenses
|
|
812
|
|
|
86,366
|
|
|
10,237
|
|
|
25,777
|
|
|
(10,119
|
)
|
|
113,073
|
|
||||||
(Loss) income from operations
|
|
(812
|
)
|
|
329,271
|
|
|
180,518
|
|
|
15,677
|
|
|
—
|
|
|
524,654
|
|
||||||
Interest expense
|
|
(21,321
|
)
|
|
(5
|
)
|
|
(2,232
|
)
|
|
(94
|
)
|
|
5,103
|
|
|
(18,549
|
)
|
||||||
Other income (expense), net
|
|
16,387
|
|
|
(6,544
|
)
|
|
39
|
|
|
26,375
|
|
|
(5,103
|
)
|
|
31,154
|
|
||||||
(Loss) income before income taxes
|
|
(5,746
|
)
|
|
322,722
|
|
|
178,325
|
|
|
41,958
|
|
|
—
|
|
|
537,259
|
|
||||||
(Benefit from) provision for income taxes
|
|
(1,976
|
)
|
|
175,170
|
|
|
426
|
|
|
3,171
|
|
|
—
|
|
|
176,791
|
|
||||||
Equity in net income of subsidiaries
|
|
355,207
|
|
|
156,690
|
|
|
—
|
|
|
21,209
|
|
|
(533,106
|
)
|
|
—
|
|
||||||
Net income
|
|
351,437
|
|
|
304,242
|
|
|
177,899
|
|
|
59,996
|
|
|
(533,106
|
)
|
|
360,468
|
|
||||||
Net income attributable to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,031
|
|
|
—
|
|
|
9,031
|
|
||||||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
351,437
|
|
|
$
|
304,242
|
|
|
$
|
177,899
|
|
|
$
|
50,965
|
|
|
$
|
(533,106
|
)
|
|
$
|
351,437
|
|
Comprehensive income attributable to
Westlake Chemical Corporation
|
|
$
|
310,946
|
|
|
$
|
304,620
|
|
|
$
|
177,899
|
|
|
$
|
9,513
|
|
|
$
|
(492,032
|
)
|
|
$
|
310,946
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net income
|
|
$
|
234,252
|
|
|
$
|
198,563
|
|
|
$
|
187,418
|
|
|
$
|
57,065
|
|
|
$
|
(432,742
|
)
|
|
$
|
244,556
|
|
Adjustments to reconcile net income to net cash
provided by operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Depreciation and amortization
|
|
417
|
|
|
71,640
|
|
|
41,182
|
|
|
20,142
|
|
|
—
|
|
|
133,381
|
|
||||||
Deferred income taxes
|
|
(4,802
|
)
|
|
105,828
|
|
|
320
|
|
|
1,644
|
|
|
—
|
|
|
102,990
|
|
||||||
Net changes in working capital and other
|
|
(275,002
|
)
|
|
(194,894
|
)
|
|
(40,445
|
)
|
|
(33,436
|
)
|
|
432,742
|
|
|
(111,035
|
)
|
||||||
Net cash (used for) provided by operating activities
|
|
(45,135
|
)
|
|
181,137
|
|
|
188,475
|
|
|
45,415
|
|
|
—
|
|
|
369,892
|
|
||||||
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Additions to property, plant and equipment
|
|
—
|
|
|
(101,270
|
)
|
|
(168,533
|
)
|
|
(17,357
|
)
|
|
—
|
|
|
(287,160
|
)
|
||||||
Proceeds from disposition of assets
|
|
—
|
|
|
7
|
|
|
98
|
|
|
—
|
|
|
—
|
|
|
105
|
|
||||||
Proceeds from sales and maturities of securities
|
|
302,432
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
302,432
|
|
||||||
Purchase of securities
|
|
(130,830
|
)
|
|
(7,592
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(138,422
|
)
|
||||||
Settlements of derivative instruments
|
|
—
|
|
|
(3,372
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,372
|
)
|
||||||
Net cash provided by (used for) investing activities
|
|
171,602
|
|
|
(112,227
|
)
|
|
(168,435
|
)
|
|
(17,357
|
)
|
|
—
|
|
|
(126,417
|
)
|
||||||
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Intercompany financing
|
|
106,904
|
|
|
(233,536
|
)
|
|
131,832
|
|
|
(5,200
|
)
|
|
—
|
|
|
—
|
|
||||||
Intercompany financing—OpCo
|
|
—
|
|
|
500
|
|
|
(500
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Debt issuance costs
|
|
(9,700
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9,700
|
)
|
||||||
Dividends paid
|
|
(47,317
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(47,317
|
)
|
||||||
Distributions paid
|
|
—
|
|
|
158,393
|
|
|
(172,463
|
)
|
|
5,986
|
|
|
—
|
|
|
(8,084
|
)
|
||||||
Proceeds from exercise of stock options
|
|
481
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
481
|
|
||||||
Proceeds from issuance of notes payable
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,842
|
|
|
—
|
|
|
3,842
|
|
||||||
Repayment of notes payable
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(8,626
|
)
|
|
—
|
|
|
(8,626
|
)
|
||||||
Repurchase of common stock for treasury
|
|
(67,404
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(67,404
|
)
|
||||||
Windfall tax benefits from share-based payment arrangements
|
|
319
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
319
|
|
||||||
Net cash used for financing activities
|
|
(16,717
|
)
|
|
(74,643
|
)
|
|
(41,131
|
)
|
|
(3,998
|
)
|
|
—
|
|
|
(136,489
|
)
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
Effect of exchange rate changes on cash and cash equivalents
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,486
|
|
|
—
|
|
|
1,486
|
|
||||||
Net increase (decrease) in cash and cash equivalents
|
|
109,750
|
|
|
(5,733
|
)
|
|
(21,091
|
)
|
|
25,546
|
|
|
—
|
|
|
108,472
|
|
||||||
Cash and cash equivalents at beginning of period
|
|
303,131
|
|
|
6,828
|
|
|
163,430
|
|
|
189,136
|
|
|
—
|
|
|
662,525
|
|
||||||
Cash and cash equivalents at end of period
|
|
$
|
412,881
|
|
|
$
|
1,095
|
|
|
$
|
142,339
|
|
|
$
|
214,682
|
|
|
$
|
—
|
|
|
$
|
770,997
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net income
|
|
$
|
351,437
|
|
|
$
|
304,242
|
|
|
$
|
177,899
|
|
|
$
|
59,996
|
|
|
$
|
(533,106
|
)
|
|
$
|
360,468
|
|
Adjustments to reconcile net income to net cash (used for)
provided by operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Depreciation and amortization
|
|
1,002
|
|
|
59,792
|
|
|
40,195
|
|
|
18,994
|
|
|
—
|
|
|
119,983
|
|
||||||
Deferred income taxes
|
|
(40
|
)
|
|
929
|
|
|
(234
|
)
|
|
2,433
|
|
|
—
|
|
|
3,088
|
|
||||||
Net changes in working capital and other
|
|
(371,716
|
)
|
|
(310,600
|
)
|
|
15,748
|
|
|
85,278
|
|
|
533,106
|
|
|
(48,184
|
)
|
||||||
Net cash (used for) provided by operating activities
|
|
(19,317
|
)
|
|
54,363
|
|
|
233,608
|
|
|
166,701
|
|
|
—
|
|
|
435,355
|
|
||||||
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Acquisition of business, net of cash acquired
|
|
—
|
|
|
—
|
|
|
—
|
|
|
15,782
|
|
|
—
|
|
|
15,782
|
|
||||||
Additions to property, plant and equipment
|
|
—
|
|
|
(95,363
|
)
|
|
(95,514
|
)
|
|
(13,056
|
)
|
|
—
|
|
|
(203,933
|
)
|
||||||
Proceeds from sales and maturities of securities
|
|
15,037
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
15,037
|
|
||||||
Settlements of derivative instruments
|
|
—
|
|
|
(1,174
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,174
|
)
|
||||||
Net cash provided by (used for) investing activities
|
|
15,037
|
|
|
(96,537
|
)
|
|
(95,514
|
)
|
|
2,726
|
|
|
—
|
|
|
(174,288
|
)
|
||||||
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Intercompany financing
|
|
208,692
|
|
|
(269,281
|
)
|
|
53,354
|
|
|
7,235
|
|
|
—
|
|
|
—
|
|
||||||
Intercompany financing—OpCo
|
|
—
|
|
|
135,341
|
|
|
(135,341
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Dividends paid
|
|
(43,896
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(43,896
|
)
|
||||||
Distributions paid
|
|
—
|
|
|
176,980
|
|
|
(189,103
|
)
|
|
4,905
|
|
|
—
|
|
|
(7,218
|
)
|
||||||
Purchase of limited partner interests
|
|
—
|
|
|
—
|
|
|
135,341
|
|
|
(135,341
|
)
|
|
—
|
|
|
—
|
|
||||||
Proceeds from exercise of stock options
|
|
831
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
831
|
|
||||||
Proceeds from issuance of notes payable
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,392
|
|
|
—
|
|
|
2,392
|
|
||||||
Repayment of notes payable
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,299
|
)
|
|
—
|
|
|
(4,299
|
)
|
||||||
Repurchase of common stock for treasury
|
|
(62,804
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(62,804
|
)
|
||||||
Windfall tax benefits from share-based payment arrangements
|
|
1,895
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,895
|
|
||||||
Net cash provided by (used for) financing activities
|
|
104,718
|
|
|
43,040
|
|
|
(135,749
|
)
|
|
(125,108
|
)
|
|
—
|
|
|
(113,099
|
)
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
Effect of exchange rate changes on cash and cash equivalents
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,000
|
)
|
|
—
|
|
|
(2,000
|
)
|
||||||
Net increase in cash and cash equivalents
|
|
100,438
|
|
|
866
|
|
|
2,345
|
|
|
42,319
|
|
|
—
|
|
|
145,968
|
|
||||||
Cash and cash equivalents at beginning of period
|
|
655,947
|
|
|
3,057
|
|
|
131,545
|
|
|
90,052
|
|
|
—
|
|
|
880,601
|
|
||||||
Cash and cash equivalents at end of period
|
|
$
|
756,385
|
|
|
$
|
3,923
|
|
|
$
|
133,890
|
|
|
$
|
132,371
|
|
|
$
|
—
|
|
|
$
|
1,026,569
|
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
(dollars in thousands, except per share data)
|
||||||||||||||
Net external sales
|
|
|
|
|
|
|
|
|
||||||||
Olefins
|
|
|
|
|
|
|
|
|
||||||||
Polyethylene
|
|
$
|
371,658
|
|
|
$
|
450,482
|
|
|
$
|
717,690
|
|
|
$
|
859,914
|
|
Styrene, feedstock and other
|
|
122,826
|
|
|
170,396
|
|
|
207,814
|
|
|
344,041
|
|
||||
Total Olefins
|
|
494,484
|
|
|
620,878
|
|
|
925,504
|
|
|
1,203,955
|
|
||||
Vinyls
|
|
|
|
|
|
|
|
|
||||||||
PVC, caustic soda and other
|
|
462,472
|
|
|
429,878
|
|
|
893,374
|
|
|
846,866
|
|
||||
Building products
|
|
129,105
|
|
|
134,246
|
|
|
242,370
|
|
|
237,712
|
|
||||
Total Vinyls
|
|
591,577
|
|
|
564,124
|
|
|
1,135,744
|
|
|
1,084,578
|
|
||||
Total
|
|
$
|
1,086,061
|
|
|
$
|
1,185,002
|
|
|
$
|
2,061,248
|
|
|
$
|
2,288,533
|
|
|
|
|
|
|
|
|
|
|
||||||||
Income (loss) from operations
|
|
|
|
|
|
|
|
|
||||||||
Olefins
|
|
$
|
140,564
|
|
|
$
|
220,938
|
|
|
$
|
289,799
|
|
|
$
|
412,041
|
|
Vinyls
|
|
52,208
|
|
|
87,966
|
|
|
114,324
|
|
|
135,052
|
|
||||
Corporate and other
|
|
(12,834
|
)
|
|
(13,530
|
)
|
|
(21,909
|
)
|
|
(22,439
|
)
|
||||
Total income from operations
|
|
179,938
|
|
|
295,374
|
|
|
382,214
|
|
|
524,654
|
|
||||
Interest expense
|
|
(5,915
|
)
|
|
(8,958
|
)
|
|
(12,600
|
)
|
|
(18,549
|
)
|
||||
Other income, net
|
|
8,181
|
|
|
22,058
|
|
|
10,826
|
|
|
31,154
|
|
||||
Provision for income taxes
|
|
66,584
|
|
|
98,413
|
|
|
135,884
|
|
|
176,791
|
|
||||
Net income
|
|
115,620
|
|
|
210,061
|
|
|
244,556
|
|
|
360,468
|
|
||||
Net income attributable to noncontrolling interests
|
|
4,496
|
|
|
4,966
|
|
|
10,304
|
|
|
9,031
|
|
||||
Net income attributable to
Westlake Chemical Corporation
|
|
$
|
111,124
|
|
|
$
|
205,095
|
|
|
$
|
234,252
|
|
|
$
|
351,437
|
|
Diluted earnings per share
|
|
$
|
0.85
|
|
|
$
|
1.54
|
|
|
$
|
1.79
|
|
|
$
|
2.64
|
|
EBITDA
(1)
|
|
$
|
255,369
|
|
|
$
|
377,772
|
|
|
$
|
526,004
|
|
|
$
|
674,789
|
|
(1)
|
See "Reconciliation of EBITDA to Net Income and to Net Cash Provided by Operating Activities" below.
|
|
|
Three Months Ended June 30, 2016
|
|
Six Months Ended June 30, 2016
|
||||||||
|
|
Average
Sales Price |
|
Volume
|
|
Average
Sales Price |
|
Volume
|
||||
Product sales price and volume percentage change
from prior-year period
|
|
|
|
|
|
|
|
|
||||
Olefins
|
|
-12.1
|
%
|
|
-8.3
|
%
|
|
-14.3
|
%
|
|
-8.8
|
%
|
Vinyls
|
|
-6.2
|
%
|
|
+11.1
|
%
|
|
-6.8
|
%
|
|
+11.5
|
%
|
Company average
|
|
-9.3
|
%
|
|
+0.9
|
%
|
|
-10.8
|
%
|
|
+0.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||
Average industry prices
(1)
|
|
|
|
|
|
|
|
|
||||
Ethane (cents/lb)
|
|
6.8
|
|
|
6.2
|
|
|
6.1
|
|
|
6.2
|
|
Propane (cents/lb)
|
|
11.7
|
|
|
10.8
|
|
|
10.4
|
|
|
11.7
|
|
Ethylene (cents/lb)
(2)
|
|
25.9
|
|
|
36.1
|
|
|
23.5
|
|
|
36.3
|
|
Polyethylene (cents/lb)
(3)
|
|
75.0
|
|
|
78.3
|
|
|
71.7
|
|
|
77.5
|
|
Styrene (cents/lb)
(4)
|
|
65.2
|
|
|
65.8
|
|
|
61.6
|
|
|
60.1
|
|
Caustic soda ($/short ton)
(5)
|
|
611.7
|
|
|
576.7
|
|
|
597.1
|
|
|
582.5
|
|
Chlorine ($/short ton)
(6)
|
|
296.7
|
|
|
268.3
|
|
|
290.8
|
|
|
253.8
|
|
PVC (cents/lb)
(7)
|
|
70.5
|
|
|
67.5
|
|
|
67.7
|
|
|
66.5
|
|
(1)
|
Industry pricing data was obtained from IHS Chemical. We have not independently verified the data.
|
(2)
|
Represents average North American spot prices of ethylene over the period as reported by IHS Chemical.
|
(3)
|
Represents average North American contract prices of polyethylene low density GP-Film grade over the period as reported by IHS Chemical.
|
(4)
|
Represents average North American contract prices of styrene over the period as reported by IHS Chemical.
|
(5)
|
Represents average North American undiscounted contract prices of caustic soda over the period as reported by IHS Chemical.
|
(6)
|
Represents average North American contract prices of chlorine (into chemicals) over the period as reported by IHS Chemical.
|
(7)
|
Represents average North American contract prices of PVC over the period as reported by IHS Chemical.
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
(dollars in thousands)
|
||||||||||||||
EBITDA
|
|
$
|
255,369
|
|
|
$
|
377,772
|
|
|
$
|
526,004
|
|
|
$
|
674,789
|
|
Less:
|
|
|
|
|
|
|
|
|
||||||||
Provision for income taxes
|
|
66,584
|
|
|
98,413
|
|
|
135,884
|
|
|
176,791
|
|
||||
Interest expense
|
|
5,915
|
|
|
8,958
|
|
|
12,600
|
|
|
18,549
|
|
||||
Depreciation and amortization
|
|
67,250
|
|
|
60,340
|
|
|
132,964
|
|
|
118,981
|
|
||||
Net income
|
|
115,620
|
|
|
210,061
|
|
|
244,556
|
|
|
360,468
|
|
||||
Changes in operating assets and liabilities and other
|
|
80,984
|
|
|
36,981
|
|
|
22,346
|
|
|
71,799
|
|
||||
Deferred income taxes
|
|
44,353
|
|
|
(2,243
|
)
|
|
102,990
|
|
|
3,088
|
|
||||
Net cash provided by operating activities
|
|
$
|
240,957
|
|
|
$
|
244,799
|
|
|
$
|
369,892
|
|
|
$
|
435,355
|
|
•
|
future operating rates, margins, cash flow and demand for our products;
|
•
|
industry market outlook, including the price of crude oil;
|
•
|
production capacities;
|
•
|
currency devaluation;
|
•
|
our ability to borrow additional funds under our credit facility;
|
•
|
our ability to meet our liquidity needs;
|
•
|
our ability to meet debt obligations under our debt instruments;
|
•
|
our intended quarterly dividends;
|
•
|
future capacity additions and expansions in the industry;
|
•
|
timing, funding and results of capital projects, such as the expansion program at our Calvert City facility;
|
•
|
results of acquisitions, including our planned transaction to acquire Axiall (including financing of the transaction and the benefits, results, effects and timing thereof);
|
•
|
pension plan obligations, funding requirements and investment policies;
|
•
|
compliance with present and future environmental regulations and costs associated with environmentally related penalties, capital expenditures, remedial actions and proceedings, including any new laws, regulations or treaties that may come into force to limit or control carbon dioxide and other greenhouse gases emissions or to address other issues of climate change;
|
•
|
effects of pending legal proceedings; and
|
•
|
timing of and amount of capital expenditures.
|
•
|
general economic and business conditions;
|
•
|
the cyclical nature of the chemical industry;
|
•
|
the availability, cost and volatility of raw materials and energy;
|
•
|
uncertainties associated with the United States, European and worldwide economies, including those due to political tensions and unrest in the Middle East, the Commonwealth of Independent States (including Ukraine) and elsewhere;
|
•
|
current and potential governmental regulatory actions in the United States and other countries and political unrest in other areas;
|
•
|
industry production capacity and operating rates;
|
•
|
the supply/demand balance for our products;
|
•
|
competitive products and pricing pressures;
|
•
|
instability in the credit and financial markets;
|
•
|
access to capital markets;
|
•
|
terrorist acts;
|
•
|
operating interruptions (including leaks, explosions, fires, weather-related incidents, mechanical failure, unscheduled downtime, labor difficulties, transportation interruptions, spills and releases and other environmental risks);
|
•
|
changes in laws or regulations;
|
•
|
technological developments;
|
•
|
our ability to consummate the Merger;
|
•
|
business uncertainties while the Merger is pending;
|
•
|
our ability to realize anticipated benefits of the Merger and to integrate Axiall's business;
|
•
|
charges or other liabilities relating to the Merger;
|
•
|
the significant indebtedness that we may incur in connection with the Merger;
|
•
|
our ability to integrate acquired businesses other than Axiall;
|
•
|
foreign currency exchange risks;
|
•
|
our ability to implement our business strategies; and
|
•
|
creditworthiness of our customers.
|
Item 3.
|
Quantitative and Qualitative Disclosures about Market Risk
|
Item 4.
|
Controls and Procedures
|
Item 1.
|
Legal Proceedings
|
Item 1A.
|
Risk Factors
|
•
|
we will be required to pay certain costs and expenses relating to the proposed transaction;
|
•
|
matters relating to the transaction (including integration planning) may have required substantial commitments of time and resources by our management, which could otherwise have been devoted to other opportunities that may have been beneficial to us; and
|
•
|
we also could be subject to litigation related to a failure to consummate the transaction or related to any enforcement proceeding commenced against us to perform our obligations under the Merger Agreement.
|
•
|
the diversion of management's attention to integration matters;
|
•
|
difficulties in achieving anticipated cost savings, synergies, business opportunities and growth prospects from combining Axiall's business with our business;
|
•
|
difficulties entering new markets or manufacturing in new geographies where we have no or limited direct prior experience;
|
•
|
difficulties in the integration of operations and systems;
|
•
|
difficulties in the assimilation of employees;
|
•
|
difficulties in managing the expanded operations of a significantly larger and more complex company;
|
•
|
successfully managing relationships with our strategic partners and our supplier and customer base;
|
•
|
challenges in maintaining existing, and establishing new, business relationships; and
|
•
|
challenges in attracting and retaining key personnel.
|
•
|
a portion of our cash flow from operations will be dedicated to the payment of interest and principal on our debt and will not be available for other purposes, including the payment of dividends;
|
•
|
we may not be able to obtain necessary financing in the future for working capital, capital expenditures, acquisitions, debt service requirements or other purposes;
|
•
|
our less leveraged competitors could have a competitive advantage because they have greater flexibility to utilize their cash flow to improve their operations;
|
•
|
we may be exposed to risks inherent in interest rate fluctuations because some of our borrowings are at variable rates of interest, which would result in higher interest expense in the event of increases in interest rates;
|
•
|
we could be vulnerable in the event of a downturn in our business that would leave us less able to take advantage of significant business opportunities and to react to changes in our business and in market or industry conditions; and
|
•
|
should we pursue additional expansions of existing assets or acquisition of third party assets, we may not be able to obtain additional liquidity at cost effective interest rates.
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
Period
|
|
Total Number
of Shares
Purchased
|
|
Average Price
Paid Per
Share
|
|
Total Number
of Shares
Purchased as Part
of Publicly
Announced Plans
or Programs
(2)
|
|
Maximum Number
(or Approximate
Dollar Value) of
Shares that
May Yet Be
Purchased Under the
Plans or Programs
(2)
|
||||||
April 2016
|
|
75
|
|
(1)
|
$
|
46.03
|
|
|
—
|
|
|
$
|
238,012,000
|
|
May 2016
|
|
1,266,009
|
|
(2)
|
$
|
44.03
|
|
|
1,266,009
|
|
|
$
|
182,275,000
|
|
June 2016
|
|
245,100
|
|
(2)
|
$
|
44.84
|
|
|
245,100
|
|
|
$
|
171,285,000
|
|
|
|
1,511,184
|
|
|
$
|
44.16
|
|
|
1,511,109
|
|
|
|
(1)
|
Represents shares withheld in satisfaction of withholding taxes due upon the vesting of restricted stock units granted to our employees under the 2013 Plan.
|
(2)
|
In November 2014, our Board of Directors authorized a $250.0 million share repurchase program (the "2014 Program"). In November 2015, our Board of Directors approved the expansion of the 2014 Program by an additional $150.0 million. As of
June 30, 2016
,
4,193,598
shares of common stock had been acquired at an aggregate purchase price of approximately
$228.7 million
under the 2014 Program. Transaction fees and commissions are not reported in the average price paid per share in the table above. Decisions regarding the amount and the timing of purchases under the 2014 Program will be influenced by our cash on hand, our cash flow from operations, general market conditions and other factors. The 2014 Program may be discontinued by our Board of Directors at any time.
|
Item 6.
|
Exhibits
|
Exhibit No.
|
|
|
|
|
|
2.1
|
|
Agreement and Plan of Merger, dated June 10, 2016, by and among Westlake Chemical Corporation, Lagoon Merger Sub, Inc. and Axiall Corporation (incorporated by reference to Exhibit 2.1 to Westlake's Current Report on Form 8-K, filed on June 14, 2016, File No. 001-32260)
|
|
|
|
10.1
|
|
Commitment Letter, dated June 10, 2016, by and among Westlake Chemical Corporation, Deutsche Bank AG Cayman Islands Branch, Deutsche Bank Securities Inc. and Goldman Sachs Bank USA (incorporated by reference to Exhibit 10.1 to Westlake's Current Report on Form 8-K, filed on June 14, 2016, File No. 001-32260)
|
|
|
|
31.1†
|
|
Rule 13a – 14(a) / 15d – 14(a) Certification (Principal Executive Officer)
|
|
|
|
31.2†
|
|
Rule 13a – 14(a) / 15d – 14(a) Certification (Principal Financial Officer)
|
|
|
|
32.1#
|
|
Section 1350 Certification (Principal Executive Officer and Principal Financial Officer)
|
|
|
|
99.1#
|
|
Unaudited Financial Statements of Non Wholly-Owned Subsidiary Guarantor (Westlake Chemical OpCo LP)
|
|
|
|
101.INS†
|
|
XBRL Instance Document
|
|
|
|
101.SCH†
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
101.CAL†
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
101.DEF†
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
101.LAB†
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
101.PRE†
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
†
|
Filed herewith.
|
#
|
Furnished herewith.
|
|
|
|
|
WESTLAKE CHEMICAL CORPORATION
|
||
|
|
|
|
|||
Date:
|
August 9, 2016
|
|
|
By:
|
|
/
S
/ A
LBERT
C
HAO
|
|
|
|
|
|
|
Albert Chao
|
|
|
|
|
|
|
President and Chief Executive Officer
(Principal Executive Officer)
|
|
|
|
|
|||
Date:
|
August 9, 2016
|
|
|
By:
|
|
/
S
/ M. S
TEVEN
B
ENDER
|
|
|
|
|
|
|
M. Steven Bender
|
|
|
|
|
|
|
Senior Vice President, Chief Financial Officer
and Treasurer
(Principal Financial Officer)
|
Exhibit No.
|
|
Exhibit
|
|
|
|
2.1
|
|
Agreement and Plan of Merger, dated June 10, 2016, by and among Westlake Chemical Corporation, Lagoon Merger Sub, Inc. and Axiall Corporation (incorporated by reference to Exhibit 2.1 to Westlake's Current Report on Form 8-K, filed on June 14, 2016, File No. 001-32260)
|
|
|
|
10.1
|
|
Commitment Letter, dated June 10, 2016, by and among Westlake Chemical Corporation, Deutsche Bank AG Cayman Islands Branch, Deutsche Bank Securities Inc. and Goldman Sachs Bank USA (incorporated by reference to Exhibit 10.1 to Westlake's Current Report on Form 8-K, filed on June 14, 2016, File No. 001-32260)
|
|
|
|
31.1†
|
|
Rule 13a – 14(a) / 15d – 14(a) Certification (Principal Executive Officer)
|
|
|
|
31.2†
|
|
Rule 13a – 14(a) / 15d – 14(a) Certification (Principal Financial Officer)
|
|
|
|
32.1#
|
|
Section 1350 Certification (Principal Executive Officer and Principal Financial Officer)
|
|
|
|
99.1#
|
|
Unaudited Financial Statements of Non Wholly-Owned Subsidiary Guarantor (Westlake Chemical OpCo LP)
|
|
|
|
101.INS†
|
|
XBRL Instance Document
|
|
|
|
101.SCH†
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
101.CAL†
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
101.DEF†
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
101.LAB†
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
101.PRE†
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
†
|
Filed herewith.
|
#
|
Furnished herewith.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|